Thesis (Pharmaceuticals) Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $13.5M

  • Investors
  • 13

Thesis (Pharmaceuticals) General Information

Description

Provider of supplements intended to make the brain more effective. The company's supplements are personalized according to the user's needs and provide on-demand focus, energy, and productivity, enabling consumers who struggle with brain fog and burnout to access a tailored product for their unique biology and daily activities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30 West 24th Street
  • Floor 11
  • New York, NY 10010
  • United States
+1 (646)
Primary Industry
Other Consumer Non-Durables
Corporate Office
  • 30 West 24th Street
  • Floor 11
  • New York, NY 10010
  • United States
+1 (646)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thesis (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 02-May-2023 $13.5M Completed Generating Revenue
3. Early Stage VC (Series A) 01-Sep-2021 Completed Startup
2. Accelerator/Incubator 01-Jul-2019 $60K $5.16M Completed Startup
1. Seed Round $5.1M $5.1M Completed Startup
To view Thesis (Pharmaceuticals)’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Thesis (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of supplements intended to make the brain more effective. The company's supplements are personalized according
Other Consumer Non-Durables
New York, NY
47 As of 2024

Royal Leamington Spa, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thesis (Pharmaceuticals) Competitors (1)

One of Thesis (Pharmaceuticals)’s competitors is Opti-Nutra, a Corporation company based in Royal Leamington Spa, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Opti-Nutra Corporation Royal Leamington Spa, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Thesis (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thesis (Pharmaceuticals) Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emil Capital Partners Venture Capital Minority
Evolution VC Partners Venture Capital Minority
Spectre Holdings Family Office Minority
Studio Management Venture Capital Minority
Artfo Holdings Family Office Minority
You’re viewing 5 of 13 investors. Get the full list »

Thesis (Pharmaceuticals) FAQs

  • When was Thesis (Pharmaceuticals) founded?

    Thesis (Pharmaceuticals) was founded in 2017.

  • Where is Thesis (Pharmaceuticals) headquartered?

    Thesis (Pharmaceuticals) is headquartered in New York, NY.

  • What is the size of Thesis (Pharmaceuticals)?

    Thesis (Pharmaceuticals) has 47 total employees.

  • What industry is Thesis (Pharmaceuticals) in?

    Thesis (Pharmaceuticals)’s primary industry is Other Consumer Non-Durables.

  • Is Thesis (Pharmaceuticals) a private or public company?

    Thesis (Pharmaceuticals) is a Private company.

  • What is Thesis (Pharmaceuticals)’s current revenue?

    The current revenue for Thesis (Pharmaceuticals) is .

  • How much funding has Thesis (Pharmaceuticals) raised over time?

    Thesis (Pharmaceuticals) has raised $27.1M.

  • Who are Thesis (Pharmaceuticals)’s investors?

    Emil Capital Partners, Evolution VC Partners, Spectre Holdings, Studio Management, and Artfo Holdings are 5 of 13 investors who have invested in Thesis (Pharmaceuticals).

  • Who are Thesis (Pharmaceuticals)’s competitors?

    Opti-Nutra is a competitor of Thesis (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process